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Sub-Saharan AfricaMalaria continues to be a life-threatening illness throughout Sub-Saharan Africa, with pregnant women and
children being particularly vulnerable and an estimated 10 000 women and 200 000 newborns dying each
year as a result of malaria in pregnancy (MIP). Since 2004, WHO has supported a three-pronged MIP approach:
(1) intermittent preventive treatment with sulfadoxine-pyrimethamine; (2) use of insecticide-treated bed nets;
and (3) effective case management. The present article identiﬁes benchmarks in Jhpiego’s 10-plus years of MIP
experience at the regional and national levels that have contributed to its global MIP leadership and aligned
programs and policies with global approaches toward malaria elimination. As countries continue to develop
and expand MIP programming, support will continue to be essential in the following eight MIP program areas:
integration, policy, capacity development, community engagement, quality assurance, commodities, monitoring
and evaluation, and ﬁnancing.
© 2015 Published by Elsevier Ireland Ltd. on behalf of International Federation of Gynecology andObstetrics. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The 2013 World Malaria Report estimated that malaria led to
207 million cases of malaria illness and an estimated 627 000 deaths
in 2012 worldwide [1]. Ninety percent of all malaria deaths occur in
Sub-Saharan Africa due to infections caused by the Plasmodium
falciparum parasite. Pregnant women and young children are among
the most vulnerable populations. Each year, approximately 25 million
African women become pregnant in malaria-endemic areas of Africa
with intense transmission of P. falciparum [2]. An estimated 10 000 of
these women and 200 000 of their newborns die as a result of malaria
in pregnancy (MIP) [3,4].
In areas of stable malaria transmission, WHO supports a three-
pronged approach to addressing MIP, ideally delivered through antena-
tal care: (1) intermittent preventive treatment (IPTp), with sulfadoxine-
pyrimethamine (SP) (IPTp-SP); (2) use of insecticide-treated bed nets
(ITNs), speciﬁcally long-lasting insecticide-treated nets (LLINs) and
(3) effective case management of malaria illness [5]. WHO’s three-
pronged MIP approach, ofﬁcially made policy in 2004, marked a pivotal
change inMIP programming from the use ofweekly chemoprophylaxis.et, Baltimore, MD 21231, USA.
).
behalf of International Federation ofIn 2000, in Abuja, Nigeria, the Roll Back Malaria (RBM) Partnership
set a target coverage rate for these three interventions of 80% by 2010
[6]. Since then, the RBM partnership has set targets for IPTp uptake
and universal coverage for LLINs at 100% [7]. The US President’s Malaria
Initiative (PMI) targets are 85% for both IPTp and ITN coverage for those
countries with PMI support [8]. While 39 countries in Sub-Saharan
Africa have MIP policies in place, most countries are far from achieving
target coverage goals for these interventions [9].
For more than a decade, Jhpiego has been a committed partner to
the RBM partnership, which includes governments of endemic coun-
tries, nongovernmental organizations, donor organizations, and
corporate members. Jhpiego has been involved in advancing the
MIP global dialogue through the RBM MIP Working Group as an
active technical participant since the group’s inception and has
served as co-chair for seven years. In addition, Jhpiego has provided
technical assistance to more than 20 countries to help accelerate
malaria prevention and control. The present article presents an
historical overview of Jhpiego’s MIP programs starting around
2002, reviewing the methods by which Jhpiego has achieved leader-
ship in MIP control. It presents as benchmarks the seminal contribu-
tions of Jhpiego in three countries (Burkina Faso, Kenya, and Nigeria)
as well as regional MIP efforts in Sub-Saharan Africa. We examine
gaps in implementation and key actions required to ensure
scale-up of MIP interventions across the region to guide other
implementing organizations.Gynecology and Obstetrics. This is an open access article under the CC BY-NC-ND license
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Jhpiego’s MIP programming is represented in the present paper
using a case study approach documenting Jhpiego’s contribution to
major benchmarks in MIP program evolution. Benchmarks were
deﬁned as either technical or managerial innovations that moved MIP
efforts to the next level of comprehensiveness and expanded coverage
of MIP interventions. A start date of around 2002 was chosen because
thatwaswhen both theMIPworking group and theUS Agency for Inter-
national Development’s (USAID) Malaria Action Coalition, comprised of
USAID’s ACCESS and RPM Plus programs, the US Centers for Disease
Control and Prevention (CDC), and the WHO/AFRO, began in earnest.
Jhpiego reviewed program activity reports and other publications
over a 10-year period to identify and subsequently describe major MIP
programming benchmarks. These benchmarks included the following:
(1) testing the efﬁcacy of IPTp-SP on a platform of antenatal care
(Burkina Faso); (2) integration of focused antenatal care services
(FANC), in which providers focus on assessment and actions needed
to make decisions and provide care for each woman’s individual situa-
tion, with MIP nationwide (Kenya); (3) support to regional networks
to accelerate MIP implementation (regional); (4) documentation of
MIP program implementation processes to learn best practices and
bottlenecks (regional); and (5) adaptation of the community-directedTable 1
Benchmark contributions of Jhpeigo to malaria in pregnancy control.
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Testing the efﬁcacy of IPTp-SP
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Countries and programs were chosen for further analysis based on
their contribution to MIP programming both at the country level and
regionally. An in-depth review of publications related to target countries
in Sub-Saharan Africa, including MIP country program reports, ministry
of health (MOH) reports, strategy documents, and peer reviewed arti-
cles, was performed to determine what countries did to implement
MIP programs, what the results were, and what implementation
challenges were faced.
3. Findings
The ﬁve benchmark contributions of Jhpiego are shown in Table 1.
3.1. Benchmark 1 (technical): Testing the efﬁcacy of IPTp-SP (Burkina Faso)
In 2001, the Burkina Faso MOH, in collaboration with Jhpiego and
the CDC, designed and implemented one of the ﬁrst pilot programs in
West Africa testing FANC as a platform for malaria in pregnancy inter-
ventions [10]. A total of 23 health facilities were included in the pilot
study, and eight sites were selected for the baseline and follow-up
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of IPTp-SP that appeared to limit efﬁcacy, namely: health workers were
not following directly observed therapy to ensure IPTp uptake andwere
providing IPTp-SP on an empty stomach; and health facilities were
charging women for SP despite an MOH instruction to deliver it free of
charge. As a result, the pilot intervention adopted a comprehensive,
system-wide approach, including fostering partnerships between
reproductive health and malaria control programs; education and su-
pervision of district health staff; quality improvement at facilities; com-
munity mobilization; and improved recordkeeping [11].
Between baseline (2001) and follow-up (2004), results of the pilot
study revealed statistically signiﬁcant improvements in health out-
comes. Women attending four or more ANC visits increased from 21%
to 44% (P= 0.01); women receiving two doses of IPTp increased from
0% to 75% (P=0.02); and peripheral parasitemia decreased signiﬁcant-
ly from 22% to 15% (P b 0.0001) (Fig. 1). Other notable outcomes includ-
ed owning an ITN,which increased from22% to 46% [12]. ITN ownership
might have increased further if ITN stock-outs had not persisted at ANC
sites.
Based in part on the results of this pilot, Burkina Faso adopted an up-
datedMIP policy in 2006 that reﬂectedWHO’s three-pronged approach.
From this work, theMOH, CDC, and Jhpiego gathered evidence not only
about the efﬁcacy of IPTp, but also about the system-wide strategies
needed to manage IPTp delivery through ANC.
3.2. Benchmark 2 (technical): Integration of FANC with MIP nationwide
(Kenya)
In 1998, Kenya was one of the early adopters of WHO’s three-
pronged approach. In 2003, Kenya operationalized its MIP policy and
adopted the platform of FANC to deliver IPTp and promote ITNs. The
delivery of MIP preventive care through ANC services was pivotal, espe-
cially at that time, since Kenya was one of the ﬁrst countries in Africa to
adopt this integrated approach.
With support from the UK Department for International Develop-
ment (DFID), Jhpiego played a facilitative role of integrating the
MOH’s inputs with WHO’s original FANC model, resulting in a service
package called “Focused Antenatal Care and Malaria in Pregnancy.” The
program was launched in two phases (demonstration and expansion)
between 2002 and 2004. The demonstration phase showed whatFig. 1. Antenatal care and malaria in pregnancy-related outcomes in Burkina Faso: baseline
preventive treatment phase 2; ITN, insecticide-treated bed net; LBW, low birth weight. Reprincould be done in four pilot districts with simple, practical education
and orientation for health workers and communities—the expansion
phase reached all 19 malaria-endemic districts nationwide [12].
Key elements of the initiative were: (1) fostering partnerships
between the MOH’s Division of Reproductive Health (DRH) and the
Division ofMalaria Control (DMOC), where the DRH led implementation
and the DMOC provided technical oversight; (2) educating frontline
healthcare providers on FANC emphasizing comprehensive care, includ-
ing IPTp uptake and promotion of ITN use; (3) supportive supervision
to reinforce knowledge and skills learned in training courses and
address gaps in service delivery through coaching and mentoring; and
(4) community sensitization to create awareness about the new changes
in provision of ANC services (e.g. pregnant women were only expected
to visit the clinics for four comprehensive visits).
The CDC evaluated the Jhpiego/MOH FANC activities by conducting
pre- and post-intervention evaluations in one of the intervention dis-
tricts (Asembo) and one of the control districts (Gem), and it included
a cross-sectional household survey of women who recently delivered
at baseline (2002) and follow-up (2005) [13].
Results in Fig. 2 illustrate that uptake of IPTp1 (phase 1) and IPTp2
(phase 2) in the intervention district increased threefold, from 20.3%
to 61.7% and 9.3% to 28.3%, respectively (P b 0.05), suggesting that edu-
cation combinedwith supportive supervision and community sensitiza-
tion contributed to increased uptake of IPTp amongpregnantwomen. In
addition, women from the intervention district were more likely than
women from the control district to attend four ANC visits (17.0% versus
6.5%) and were signiﬁcantly more likely to state that SP is helpful and
safe during pregnancy [13].
3.3. Benchmark 3 (managerial): Support to regional networks to accelerate
MIP implementation (regional)
In an effort to augment country-level implementation of MIP on a
platform of FANC, Jhpiego worked closely with countries in East,
Southern, and West Africa to support the development of regional
bodies that could increase momentum, advocacy, and support for MIP
programming.
In East and Southern Africa, ﬁve countries (Kenya,Malawi, Tanzania,
Uganda, and Zambia) were early adopters ofWHO’s three-prongedMIP
approach. In 2002, representatives from these countries came together(2001) and follow-up (2004). Abbreviations: ANC, antenatal care; IPTp2, intermittent
ted with permission from Jhpiego [12].
Fig. 2. Intermittent preventive treatment (IPTp phase 1 and 2) coverage among recentmotherswho attended antenatal care in intervention and control districts in Kenya: baseline (2002)
and follow-up (2005). Adapted with permission from Ouma et al. [13].
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Southern Africa (MIPESA) coalition. Jhpiego played a key role as a
MIPESA partner [14]. Between 2002 and 2005, MIPESA transferred best
practices and lessons learned across countries, fostered partnerships
between national reproductive health and malaria control programs,
and increased regional capacity to support MIP programming at the
country level [15]. In particular, MIPESA contributed to: (1) harmonized
and appropriately integrated national policies, strategies, and education
materials in Zambia and Kenya; (2) adaptation of education materials
from Kenya to other countries (i.e. adapting training for FANC as a
platform to deliver MIP services in Tanzania, Uganda, and Malawi);
and (3) increased commitments from national reproductive health and
malaria control programs across all countries to work together to
address MIP programming.
Similarly, inMarch 2002, directors of reproductive health andmalaria
control programs in West African countries came together to consider
the way forward for addressing MIP in their region. Among their recom-
mendations was the creation of the Roll Back Malaria’s West African
Network for the Prevention and Treatment of Malaria in Pregnancy
(Réseau d’Afrique de l’Ouest contre le Paludisme pendant la Grossesse,
or RAOPAG), which expanded to 10 countries between 2003 and 2005
(Benin, Burkina Faso, Côte d’Ivoire, Guinea, Mali, Mauritania, Niger,
Nigeria, Senegal, and Togo) and multiple international partners [16].
RAOPAG’s mission was to facilitate information exchange between
member countries with respect to advocacy, research, and implementa-
tion of MIP prevention and treatment interventions, and to support
regional expertise through planning and documentation. RAOPAG was
the ﬁrst and only network inWest Africa to bring together reproductive
health and malaria control experts regionally to share knowledge and
lessons learned in MIP prevention and control [15,16].
Other RAOPAG contributions included: (1) fostering the creation of
country-speciﬁc action plans for policy change and acting as a catalyst
for IPTp-SP adoption in member countries; (2) creating a database of
online MIP resources, including country-speciﬁc policies, guidelines,
and action plans by country focal persons; (3) facilitating the adaptation
of FANC/MIP clinical education materials at the regional level and
organizing education of trainers at the country level; and (4) assisting
member countries in developing advocacy plans to solicit support
for their MIP action plans and marketing MIP strategies to potential
donors.These two regional networks helped reposition MIP programming
from a mere innovation to a major program component of ANC.
They also demonstrated the importance of peer inﬂuence inherent in
South-to-South dialogue and planning.
3.4. Benchmark 4 (technical): Documentation of MIP program implemen-
tation practices (regional)
While MIP program experiences from Burkina Faso and Kenya as
well as regional efforts through MIPESA and RAOPAG contributed to
acceleration of MIP programming across Sub-Saharan Africa, national
coverage of IPTpuptake and ITNs remains low. Based on themost recent
Demographic andHealth Surveys,Malaria Indicator Surveys, andMalaria
Indicator Cluster Surveys, IPTp uptake (two doses) across PMI countries
averaged 33%, ranging from 1% (Benin) to 70% (Zambia), and LLIN use
among pregnant women averaged 43%, ranging from 10% (Zimbabwe)
to 72% (Rwanda) [17]. To better understand the features of MIP
programs that work well and those that need improvement, Jhpiego,
with support from PMI, documented best practices and remaining
challenges in MIP programming in three relatively successful countries:
Zambia, Malawi, and Senegal. The results of this program assessment
have been published elsewhere and are summarized in Box 1 [18].
3.5. Benchmark 5 (technical): Community-directed interventions
Starting in 2006, Jhpiego received funding from Exxon Mobil to
address one of the more visible and challenging MIP program areas in
Nigeria: community involvement. Of primary concern was low ANC
utilization, poor community attitudes toward ANC because of low
perceived service quality, and very low coverage of IPTp and ITNs
among pregnant women.
From 2007 to 2011, Jhpiego organized a community-clinic partner-
ship, illustrated in Fig. 3, which used a two-pronged approach to
increase coverage of MIP services: (1) improving the quality of FANC
services; and (2) increasing access to MIP services through CDIs [19].
CDIs enable communities to lead health interventions in collaboration
with health facilities [20]. Health facility staff train, supervise, and pro-
vide communities with needed commodities. Communities direct
their own health promotion activities, maintain registers, decide when
Box 1
Malaria in pregnancy program areas.
Integration: Integrated MIP services include collaboration between
national reproductive health andmalaria control programs and other
comprehensive maternal and child health services programs to
ensure harmonized policies, guidelines, and education materials,
and a coordinated effective program implementation.
Policy: MIP policies are based on the latest scientific evidence,
defined country goals, and national guidelines that are harmonized
and effectively integrated across different health sectors.
Commodities:Commodities include correct medicines andmedical
products, systems that ensure commodity availability that include
SP, LLINs, diagnostic tools, rapid diagnostic tests and/or microsco-
py, and medicines to provide effective MIP case management.
Quality assurance: Quality assurance is a concept that covers
individually or collectively efficacy, safety, appropriateness, and
acceptability ofMIP servicesmeasuring quality of care, supervision
support, and self-assessment by healthcare providers to monitor
delivery of services.
Capacity Building:MIP capacity building is strengthening human
resources by improving knowledge and skills that includes compe-
tency-based pre- and in-service education based on WHO guide-
lines and national policies.
Community Awareness and Involvement: MIP community
engagement involves the promotion and/or delivery of health
services including raising awareness ofMIP prevention and control;
promotion of IPTp and ITNs; and effective case management.
Monitoring and Evaluation: Monitoring and evaluation captures
MIP service delivery indicators and provide data to the national
health management information system to be used for decision
making at all points of care and national policy formulation.
Financing:MIP financing is a combination of national government
and donor funding that guarantee that programs receive the
necessary support and resources to reach all pregnant women.
Abbreviations: MIP, malaria in pregnancy; SP, sulfadoxine-pyrimethamine; LLIN,
long-lasting insecticide-treated nets.
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service utilization (referral to comprehensive ANC services).
The two-pronged intervention was tested in three Local Govern-
ment Areas (LGAs) of Akwa Ibom State, Nigeria, using another three
LGAs as control areas. Overall, 25 health facilities and catchment com-
munities containing more than 820 000 people were involved. In the
three intervention LGAs, frontline health facilities (FLHFs) were trained
to mobilize their communities to select their own community-directed
distributors (CDDs). After a ﬁve-day education session, the 800 selected
CDDs were supervised by the FLHFs and monitored using Jhpiego’s
quality improvement approach, Standards-Based Management and
Recognition (SBM-R; Jhpiego, Baltimore, MD, USA), to detectFig. 3. Nigeria malaria in pregnancy (MIP) community–clinic partnership intervention.
Reprinted with permission from Brieger et al. [19].performance gaps that deterred ANC attendance and develop action
plans to solve them. More than 300 FLHFs in both arms of the study
were provided with basic education on FANC including MIP, record-
keeping, and use of data for decision-making purposes. Basic supplies
that included SPwere also provided to all clinics since nothingwas avail-
able at baseline. ANC registers were updated to reﬂect MIP indicators.
FLHFs in the intervention armmobilized their catchment communi-
ties for CDI and encouraged the communities to select the volunteer
CDDs, conduct a community census, and collect MIP supplies on a regu-
lar basis. CDDs provided a ﬁrst contact with MIP services, including
distributing SP and ITNs, maintaining records and submitting monthly
tally sheets, giving health education, and referring pregnant women to
ANC, thereby strengthening community–clinic links. By using CDDs,
the FLHFs were able to extend the reach of their ANC services.
In addition to technical supervision by the FLHFs, CDDs were held
accountable by their communities. Communities had selected CDDs
whom they trusted, who were able to read and write, who were resi-
dent in the community, and (perhapsmost importantly)whowerewill-
ing to volunteer their services. Two CDDs were even ﬁned and replaced
by their communities for diverting MIP commodities, demonstrating
their local accountability.
Comparing baseline and endline surveys showed a statistically
signiﬁcant (P b 0.001) ﬁve-times increase in coverage of IPTp in the
CDI communities as compared with a three-times increase in the con-
trol arm where IPTp was available only at ANC. ANC attendance was
also enhanced with community volunteers making referrals, showing
that the community–clinic partnership was working; elderly CDDs
were particularly helpful inmobilizing youngerwomen to attend clinics
and utilize available services [21].
4. The way forward
This analysis of Jhpiego’s role in global MIP control highlights key
steps and important achievements inMIP programming that helped ac-
celerate program implementation throughout Sub-SaharanAfrica. From
pilotingMIPon a platformof FANC to expansionnationally and adapting
a scientiﬁcally proven intervention strategy of CDI, aswell as supporting
the role of regional networks to further accelerate implementation,
Jhpiego’s commitment and technical expertise has contributed essential
program learning about MIP interventions, both in terms of successful
practices and remaining challenges. This learning has subsequently
been shared with and scaled up by RBM partner organizations to
improve outcomes for women and their newborns.
Despite these programmatic advances, much work remains to ad-
here toWHO guidelines and reduceMIP prevalence. Very few countries
have reached either the targets set at the Abujameeting in 2000 or their
own policy ambition, and countries are even further away from the
more recent RBM targets set for 2010 [4,7]. The newWHO IPTp recom-
mendation, disseminated in October 2012, which promotes IPTp at
every scheduled ANC visit beginning in the second trimester of preg-
nancy [22], presents an opportunity for countries to review and update
their national policies and guidelines as well as explore new MIP pro-
gram possibilities—making strategic decisions to accelerate scale-up
and further improve coverage for pregnant women.
As countries continue to expandMIP programming, comprehensive
support for the eight MIP program areas will be essential. These
program areas are the core components of any health system; if one is
weak, it impacts the others. This underscores the importance of
addressing MIP care comprehensively with attention to health system
strengthening to achieve long-lasting results. Jhpiego’s approach has
been to addressmalaria prevention and control comprehensively across
the health “continuum of care,” from the community to the health facil-
ity to the national level on a platform of maternal, child, and newborn
care, addressing each of the MIP program areas.
Underpinning the acceleration of MIP programming in each of the
country and regional case studies was the strong partnership between
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trol program, as well as the national HIV program. Both Burkina Faso
and Kenya facedmultiple bottlenecks asMIP programswere introduced
and scaled up respectively. For example, addressing issues of commod-
ities and supplies in collaboration with all stakeholders was key to
success of the program. In both countries, the dynamic partnership
between and leadership from the national reproductive health program
and the national malaria control program meant that gaps in provider
performance (i.e. understanding of guidelines, education, supervision)
could be addressed efﬁciently. These successful program initiatives in
Burkina Faso and Kenya catalyzed the introduction and expansion of
FANC services withMIP in other East, Southern, andWest African coun-
tries using the same elements of partnerships, education, supportive
supervision, and community sensitization. The pace of expansion to
other countries was hastened through Jhpiego’s participation in regional
MIP networks.
Recognizing that MIP is both a maternal and newborn health issue,
reproductive health programs should lead efforts to manage program
implementation on a platform of FANC, and national malaria control
programs should provide technical leadership including procurement
and distribution of needed MIP supplies to ANC clinics (i.e. SP, LLINs,
and treatment drugs). This critical partnership starts at the national
level, where both programs can harmonize national level MIPmaterials,
including policies, guidelines, and education materials, and coordinate
effective implementation.
To date, IPTp uptake has been the main focus of country programs;
however, ITN use and correct case management are also recognized as
essential components of a comprehensive MIP program. Engagement
with ITN partners can help to increase awareness among pregnant
women about the importance of ITN use, and the role of ANC in routine
distribution of ITNs among the partners. The eight programareas ofMIP
are essential health systems components to address when countries are
focusing on improvingMIPmorbidity andmortality rates [18]. As coun-
tries consider application of community-based distribution and/or
social mobilization models to augment their existing strategies, it will
be essential to document outcomes related to MIP prevention and
case management to better understand the feasibility and acceptability
of these approaches and guide application.
In the future, countries will need to develop or review their national
malaria control policy, strategies, and guidelines forMIP to ensure align-
ment with global approaches toward malaria elimination. The WHO’s
three-pronged approach should be an integral part of national malaria
prevention and control policies and should also be reﬂected in national
reproductive health policies. In particular, the third prong—malaria case
management—with improved diagnostics and treatment is needed as
part of case detection and surveillance among pregnant women to
better serve both women and their children.
Jhpiego continues to test new approaches that will support MIP
scale-up and help countries achieve their target goals. Ongoing collabo-
ration and support are needed to achieve Millennium Development
Goals 4 and 5 and move beyond these goals to eliminate malaria.Conﬂict of interest
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